Introduction: In the last century, there have been major changes within the population structure in Germany. The aim of this study was to determine the impact of a changing population structure on identification of familial prostate cancer (PCa), and to investigate how many and which types of other cancers have occurred in patients and their first-degree relatives. Materials and Methods: A total of 19,540 patients were evaluated in a prospectively collected PCa family database and divided into four birth cohorts: 1925–1934 (cohort A), 1935–1944 (cohort B), 1945–1954 (cohort C), and 1955–1964 (cohort D). Other primary cancers and cancers of first-degree relatives were evaluated. Results: The percentage of PCa patients with ≥2 sons declined (A: 28.9% to D: 21.6%). The percentage of patients whose fathers lived for ≥65 years increased (B: 64.2% to D: 73.0%). Malignancies of the skin, the urinary tract, and the lymphoid/hematopoietic tissue were more common in patients with a positive first-degree PCa family history and their first-degree relatives. Additionally, first-degree relatives reported more often neoplasms of respiratory/intrathoracic organs and the female breast. Conclusions: A small family size, an early deceased father, and a high number of sporadic cases complicate the identification of familial PCa patients. Thus, a detailed family history should also include unaffected first-degree relatives to avoid any misclassification. Findings of other primary cancers in patients and their relatives warrant further investigation.

1.
Záleský
M
,
Stejskal
J
,
Adamcova
V
,
Hrbáček
J
,
Minarik
I
,
Pavlicko
A
, et al.
Use of Prostate Specific Antigen Density Combined with Multiparametric Magnetic Resonance Imaging Improves Triage for Prostate Biopsy
.
Urol Int
.
2019
;
103
(
1
):
33
40
.
[PubMed]
0042-1138
2.
Steinberg
GD
,
Carter
BS
,
Beaty
TH
,
Childs
B
,
Walsh
PC
.
Family history and the risk of prostate cancer
.
Prostate
.
1990
;
17
(
4
):
337
47
.
[PubMed]
0270-4137
3.
Leitzmann
MF
,
Rohrmann
S
.
Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates
.
Clin Epidemiol
.
2012
;
4
:
1
11
.
[PubMed]
1179-1349
4.
Tan
DS
,
Mok
TS
,
Rebbeck
TR
.
Cancer Genomics: Diversity and Disparity Across Ethnicity and Geography
.
J Clin Oncol
.
2016
Jan
;
34
(
1
):
91
101
.
[PubMed]
0732-183X
5.
Zeegers
MP
,
Jellema
A
,
Ostrer
H
.
Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis
.
Cancer
.
2003
Apr
;
97
(
8
):
1894
903
.
[PubMed]
0008-543X
6.
Eeles
R
,
Goh
C
,
Castro
E
,
Bancroft
E
,
Guy
M
,
Al Olama
AA
, et al.
The genetic epidemiology of prostate cancer and its clinical implications
.
Nat Rev Urol
.
2014
Jan
;
11
(
1
):
18
31
.
[PubMed]
1759-4812
7.
Al Olama
AA
,
Kote-Jarai
Z
,
Berndt
SI
,
Conti
DV
,
Schumacher
F
,
Han
Y
, et al.;
Breast and Prostate Cancer Cohort Consortium (BPC3)
;
PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium
;
COGS (Collaborative Oncological Gene-environment Study) Consortium
;
GAME-ON/ELLIPSE Consortium
.
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer
.
Nat Genet
.
2014
Oct
;
46
(
10
):
1103
9
.
[PubMed]
1061-4036
8.
Chen
SL
,
Fann
JC
,
Sipeky
C
,
Yang
TK
,
Chiu
SY
,
Yen
AM
, et al.
Risk Prediction of Prostate Cancer with Single Nucleotide Polymorphisms (SNPs) and Prostate-Specific Antigen (PSA)
.
J Urol
.
2018
.0022-5347
9.
Ehling
M
,
Pötzsch
O
.
Demographic Changes in Germany up to 2060 - Consequences for Blood Donation
.
Transfus Med Hemother
.
2010
Jun
;
37
(
3
):
131
9
.
[PubMed]
1660-3796
10.
Seeleib-Kaiser
M
,
Toivonen
T
.
Between reforms and birth rates: Germany, Japan, and family policy discourse
.
Soc Polit
.
2011
;
18
(
3
):
331
60
.
[PubMed]
1072-4745
11.
Herkommer
K
,
Heimpel
M
,
Gschwend
JE
.
[Familial prostate cancer research: meaningfulness of hereditary criteria in view of demographic change]
.
Urologe A
.
2014
Dec
;
53
(
12
):
1779
85
.
[PubMed]
0340-2592
12.
Beebe-Dimmer
JL
,
Yee
C
,
Cote
ML
,
Petrucelli
N
,
Palmer
N
,
Bock
C
, et al.
Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women’s Health Initiative Study
.
Cancer
.
2015
Apr
;
121
(
8
):
1265
72
.
[PubMed]
0008-543X
13.
Thellenberg
C
,
Malmer
B
,
Tavelin
B
,
Grönberg
H
.
Second primary cancers in men with prostate cancer: an increased risk of male breast cancer
.
J Urol
.
2003
Apr
;
169
(
4
):
1345
8
.
[PubMed]
0022-5347
14.
Davis
EJ
,
Beebe-Dimmer
JL
,
Yee
CL
,
Cooney
KA
.
Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study
.
Cancer
.
2014
Sep
;
120
(
17
):
2735
41
.
[PubMed]
0008-543X
15.
Thalgott
M
,
Kron
M
,
Brath
JM
,
Ankerst
DP
,
Thompson
IM
,
Gschwend
JE
, et al.
Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomy
.
World J Urol
.
2018
Feb
;
36
(
2
):
177
85
.
[PubMed]
0724-4983
16.
Hemminki
K
,
Sundquist
J
,
Bermejo
JL
.
How common is familial cancer?
Ann Oncol
.
2008
Jan
;
19
(
1
):
163
7
.
[PubMed]
0923-7534
17.
Brandt
A
,
Bermejo
JL
,
Sundquist
J
,
Hemminki
K
.
Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members
.
Eur Urol
.
2010
Aug
;
58
(
2
):
275
80
.
[PubMed]
0302-2838
18.
Pishgar
F
,
Ebrahimi
H
,
Saeedi Moghaddam
S
,
Fitzmaurice
C
,
Amini
E
.
Global, Regional and National Burden of Prostate Cancer, 1990 to 2015: Results from the Global Burden of Disease Study 2015
.
J Urol
.
2018
May
;
199
(
5
):
1224
32
.
[PubMed]
0022-5347
19.
King
TM
,
Tong
L
,
Pack
RJ
,
Spencer
C
,
Amos
CI
.
Accuracy of family history of cancer as reported by men with prostate cancer
.
Urology
.
2002
Apr
;
59
(
4
):
546
50
.
[PubMed]
0090-4295
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.